National Bank Alzheimer

Alzheimer Disease Clinical Trial

— BNA  

Official title:

National Bank Alzheimer

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03687112
• Other study ID #: 18-DSP-03
• Status: Recruiting
• Start date: January 1, 2009
• Est. completion date: December 31, 2025

Study information

• Verified date: September 2018
• Source: Centre Hospitalier Universitaire de Nice
• Contact: Philippe ROBERT, PUPH
• Phone: 33492034773
• Email: robert.p[@]chu-nice.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Alzheimer's disease (MY) is a major problem of public health. The French National Database Alzheimer ( BNA) registers(records) all the medical acts made by units of memory(report) and of independent specialists in France.

In 2008, the national Plan Alzheimer 2008 - 2012 had for objective to strengthen the search(research) on the Alzheimer's disease (MY) and for related disorders(confusions), to promote an early diagnosis and to improve at the same time the management of the patients and to support careers(quarries). A specific part(party) of this plan gave rise to the creation of the French national database Alzheimer ( BNA) to supply epidemiological data as well as indicators of activity. Since 2009 The information collected(taken in) in the BNA consists of a set(group) limited by data (CIMA of information minimum Corpus Alzheimer) concerning the demographic, clinical and diagnostic data defined by national consensus. The number of variables is limited to facilitate and to improve the participation in this national database. The participants are the Centers Report (CM)((LECTURE)) and Center Memory(Report) of Resources and Search(Research) (CMRR) and independent specialists. In 2015 more than 500 Centers send CIMA to the BNA.

The plan Disease Neurodegenerative 2014 - 2019 wishes to pursue and to amplify the BNA.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 0
• Est. completion date: December 31, 2025
• Est. primary completion date: January 1, 2009
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• patients consulting in French Memory Centres

Exclusion Criteria:

Related Conditions & MeSH terms

• Alzheimer Disease

Intervention

Other:
• non ontervention / observational study
non intervention

Locations

Country	Name	City	State
France	Nice University Hospital	Nice

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nice

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	New therapeutic plans	Participate in the evaluation of new therapeutic plans of care	16 years
Primary	Evolution of the morbi-mortality	number of people suffering from a disease	16 years
Primary	Evolution of the morbi-mortality	number of deaths	16 years
Secondary	number of the miscellaneous determiners of Access to healthcare or diagnosis	number of the determiners of the access to healthcare and diagnosis	16 years